76 related articles for article (PubMed ID: 1799380)
1. Repeated dose toxicity studies on catena-(S)-[mu-[N alpha-(3-aminopropionyl) histidinato(2-)-N1,N2,O:N tau]-zinc] in rats.
Matsuda K; Mera Y; Wada H; Aruga H; Saik Y; Taniguchi Y
Arzneimittelforschung; 1991 Oct; 41(10):1036-41. PubMed ID: 1799380
[TBL] [Abstract][Full Text] [Related]
2. Single dose toxicity study on catena-(S)-[mu-[N alpha-(3-aminopropionyl) histidinato(2-)-N1,N2,O:N tau]-zinc] in mice and rats.
Matsuda K; Shibata K; Morikami H; Kato T; Aruga F
Arzneimittelforschung; 1991 Oct; 41(10):1033-5. PubMed ID: 1799379
[TBL] [Abstract][Full Text] [Related]
3. Reproductive and developmental toxicity studies on catena-(S)-[mu-[N alpha-(3-aminopropionyl) histidinato(2-)-N1,N2,O:N tau]-zinc].
Matsuda K; Nishi N; Hiramatsu Y; Shimizu M; Ohta T; Kato M
Arzneimittelforschung; 1991 Oct; 41(10):1042-8. PubMed ID: 1799381
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of the novel anti-peptic ulcer agent catena-(S)-[mu-[Na- (3-aminopropionyl)histidinato(2-)-N1,N2,Q:N tau]-zinc in male cynomolgus monkeys.
Green OP; Deoraj P; Gopinath C; Crook D; Matsuda K
Arzneimittelforschung; 1993 May; 43(5):562-9. PubMed ID: 8329001
[TBL] [Abstract][Full Text] [Related]
5. Mutagenicity studies on catena-(S)-[mu-[N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc].
Shibata K; Matsuda K; Ohta T; Sasaki Y; Sutou S
Arzneimittelforschung; 1991 Oct; 41(10):1053-7. PubMed ID: 1799383
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of the novel anti-peptic ulcer agent polaprezinc in beagle dogs.
Matsuda K; Yamaguchi I; Wada H
Arzneimittelforschung; 1995 Jan; 45(1):52-60. PubMed ID: 7893270
[TBL] [Abstract][Full Text] [Related]
7. Study on the metabolic fate of catena-(S)-[mu-N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 3rd communication: transfer into fetus and milk in rats.
Toyama S; Furuta S; Miwa M; Suzuki M; Sano H; Matsuda K
Arzneimittelforschung; 1991 Sep; 41(9):984-91. PubMed ID: 1796929
[TBL] [Abstract][Full Text] [Related]
8. Antigenicity studies on catena-(S)-[mu-[N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc].
Shibata K; Matsuda K; Wada H; Aruga F; Yamada Y
Arzneimittelforschung; 1991 Oct; 41(10):1048-52. PubMed ID: 1799382
[TBL] [Abstract][Full Text] [Related]
9. Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3- aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 2nd communication: absorption, distribution, metabolism and excretion after repeated administration to rats.
Toyama S; Furuta S; Miwa M; Suzuki M; Sano H; Matsuda K
Arzneimittelforschung; 1991 Sep; 41(9):976-83. PubMed ID: 1796928
[TBL] [Abstract][Full Text] [Related]
10. Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3- aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 1st communication: absorption, distribution, metabolism and excretion after single administration to rats.
Sano H; Furuta S; Toyama S; Miwa M; Ikeda Y; Suzuki M; Sato H; Matsuda K
Arzneimittelforschung; 1991 Sep; 41(9):965-75. PubMed ID: 1796927
[TBL] [Abstract][Full Text] [Related]
11. Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 4th communication: disposition of zinc and amino acids in rats, dogs and monkeys.
Furuta S; Toyama S; Miwa M; Ikeda Y; Sano H; Matsuda K
Arzneimittelforschung; 1991 Sep; 41(9):992-5. PubMed ID: 1796930
[TBL] [Abstract][Full Text] [Related]
12. Preventive actions of N-(3-aminopropionyl)-L-histidinato zinc (Z-103) through increases in the activities of oxygen-derived free radical scavenging enzymes in the gastric mucosa on ethanol-induced gastric mucosal damage in rats.
Ito M; Shii D; Segami T; Kojima R; Suzuki Y
Jpn J Pharmacol; 1992 Jul; 59(3):267-74. PubMed ID: 1434125
[TBL] [Abstract][Full Text] [Related]
13. Effect of the new zinc compound beta-alanyl-L-histidinato zinc on bone metabolism in elderly rats.
Yamaguchi M; Ozaki K
Pharmacology; 1990; 41(6):345-9. PubMed ID: 2096395
[TBL] [Abstract][Full Text] [Related]
14. Beta-alanyl-L-histidinato zinc prevents the toxic effect of aluminium on bone metabolism in weanling rats.
Yamaguchi M; Ozaki K
Pharmacology; 1990; 41(6):338-44. PubMed ID: 2096394
[TBL] [Abstract][Full Text] [Related]
15. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
16. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
Chan P
Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
[TBL] [Abstract][Full Text] [Related]
17. Preventive effect of beta-alanyl-L-histidinato zinc on bone metabolism in rats fed on low-calcium and vitamin D-deficient diets.
Segawa Y; Tsuzuike N; Tagashira E; Yamaguchi M
Res Exp Med (Berl); 1992; 192(3):213-9. PubMed ID: 1636066
[TBL] [Abstract][Full Text] [Related]
18. Changes in tissue contents of zinc, copper and iron in rats and beagle dogs treated with polaprezinc.
Yamaguchi I; Shibata K; Takei M; Matsuda K
J Toxicol Sci; 1996 Aug; 21(3):177-87. PubMed ID: 8887886
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of 3,3'-Dimethylbenzidine Dihydrochloride (CAS No. 612-82-8) in F344/N Rats (Drinking Water Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1991 Jun; 390():1-238. PubMed ID: 12637969
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
